DrugDashboards

Astringent

Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate · CALCIUM ACETATE MONOHYDRATE 952 mg/2299mg; ALUMINUM SULFATE TETRADECAHYDRATE 1347 mg/2299mg · Powder, For Solution · Topical · Granulation Technology, Inc.

NDC 63561-0178-02 · 12 PACKET in 1 CARTON / 2299 mg in 1 PACKET · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Xywav and Xyrem

Regulatory

Application
part347
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate (Powder, For Solution)

LabelerStrengthFirst seenLast seen
Granulation Technology, Inc.CALCIUM ACETATE MONOHYDRATE 952 mg/2299mg; ALUMINUM SULFATE TETRADECAHYDRATE 1347 mg/2299mgAug 26, 2026Sep 2, 2026
Granulation Technology, Inc.CALCIUM ACETATE MONOHYDRATE 1347 mg/2299mg; ALUMINUM SULFATE TETRADECAHYDRATE 952 mg/2299mgJul 22, 2026Aug 19, 2026
Granulation Technology, Inc.ALUMINUM SULFATE TETRADECAHYDRATE 1347 mg/2299mg; CALCIUM ACETATE MONOHYDRATE 952 mg/2299mgJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Astringent — NDC 63561-0178-02," retrieved September 3, 2026, https://drugdashboards.com/drug/63561017802.

Free to cite with attribution — see how the data is put together.